This new study identifies T cells associated with the autoimmune disease AAV

Published Date: 17 Feb 2023

Many patients with ANCA-associated autoimmune vasculitis (AAV) are at risk of disease recurrence despite treatment. Researchers at the Karolinska Institutet have just identified a T cell that contributes to the destruction of...

Read Full News

Latest News

Increases in Physician Attrition Rates Could Worsen Shortages

Increases in Physician Attrition Rates Could Worsen Shortages

Improving CRC Screening Rates With High-Quality, Noninvasive Tests, with Keith Winfrey, MD, MPH Keith Winfrey, MD, MPH

Winfrey discussed how noninvasive CRC screening tests can help meet gaps when patients face barriers to colonoscopy.

ACP Urges Concern for Health Policy Issues, with Shari Erickson, MPH Shari Erickson, MPH

Erickson discussed key health policy issues the ACP is pushing back against during the organization’s Internal Medicine meeting.

Reviving exhausted immune cells boosts tumor elimination

A new study has discovered a molecular signal that tumors exploit to exhaust the T cells meant to destroy them—and how silencing that signal could revive the body's immunity.

Precision therapy could stop breast cancer at the source

Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for triple-negative breast cancer (TNBC), which is among the most aggressive and difficult-to-treat forms of ...

What are the big unanswered questions about cancer? Experts discuss

Over the 40-year history of the University of Colorado Cancer Center, its investigators have answered many questions about cancer—what causes it, how to prevent it, and how to treat it. Those discoveries have helped many ...

Todays Updates

7 Rheumatology Headlines You Missed in October 2025 Victoria Johnson

The rheumatology month in review emphasizes new data presented at the 2025 ACR Convergence.

ACR Convergence 2025 Recap: Late-Breaking Trials to Know Victoria Johnson

A compilation of 13 trials presented as late-breaking data at ACR Convergence 2025.

Unseen Symptoms: Cognitive Decline Reveals Quality-of-Life Impacts of SLE, with Carla Cuda, PhD Carla Marie Cuda, PhD

New research at ACR 2025 highlights the link between cognitive impairment and disease activity in SLE.

This Year in Medicine 2025: Recognizing Top Advances in Healthcare HCPLive Editorial Staff

Explore groundbreaking advancements in healthcare as 2025 concludes, featuring expert insights and dynamic multimedia.

5 Rheumatology Headlines You Missed in November 2025 Victoria Johnson

This rheumatology month in review emphasizes new data from the ACR Convergence.

Firsekibart Beats Colchicine as Gout Flare Prophylaxis When Initiating ULT Victoria Johnson

New data support firsekibart's efficacy over colchicine for preventing acute gout flares.

Lingdolinurad Demonstrates Dose-Dependent Serum Uric Acid Reductions Victoria Johnson

A new study reveals ligdolinurad effectively lowers uric acid levels in gout patients, showcasing promising safety and tolerability results.

Todays Updates

7 Rheumatology Headlines You Missed in October 2025 Victoria Johnson

The rheumatology month in review emphasizes new data presented at the 2025 ACR Convergence.

ACR Convergence 2025 Recap: Late-Breaking Trials to Know Victoria Johnson

A compilation of 13 trials presented as late-breaking data at ACR Convergence 2025.

Unseen Symptoms: Cognitive Decline Reveals Quality-of-Life Impacts of SLE, with Carla Cuda, PhD Carla Marie Cuda, PhD

New research at ACR 2025 highlights the link between cognitive impairment and disease activity in SLE.

This Year in Medicine 2025: Recognizing Top Advances in Healthcare HCPLive Editorial Staff

Explore groundbreaking advancements in healthcare as 2025 concludes, featuring expert insights and dynamic multimedia.

5 Rheumatology Headlines You Missed in November 2025 Victoria Johnson

This rheumatology month in review emphasizes new data from the ACR Convergence.

Firsekibart Beats Colchicine as Gout Flare Prophylaxis When Initiating ULT Victoria Johnson

New data support firsekibart's efficacy over colchicine for preventing acute gout flares.

Lingdolinurad Demonstrates Dose-Dependent Serum Uric Acid Reductions Victoria Johnson

A new study reveals ligdolinurad effectively lowers uric acid levels in gout patients, showcasing promising safety and tolerability results.

Latest News

Increases in Physician Attrition Rates Could Worsen Shortages

Winfrey discussed how noninvasive CRC screening tests can help meet gaps when patients face barriers to colonoscopy.

Erickson discussed key health policy issues the ACP is pushing back against during the organization’s Internal Medicine meeting.

A new study has discovered a molecular signal that tumors exploit to exhaust the T cells meant to destroy them—and how silencing that signal could revive the body's immunity.

Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for triple-negative breast cancer (TNBC), which is among the most aggressive and difficult-to-treat forms of ...

Over the 40-year history of the University of Colorado Cancer Center, its investigators have answered many questions about cancer—what causes it, how to prevent it, and how to treat it. Those discoveries have helped many ...

News All Time

Global reviews call for urgent action on endometriosis in most world regions

Two reviews published in The Lancet Obstetrics, Gynecology & Women's Health reveal stark global inequities in how endometriosis is recognized, treated, and prioritized in national health systems.

Mental and physical coaching before surgery prepares immune system and reduces complications, trial finds

The weeks leading up to a major surgery can be a time of uncertainty and worry for patients, many of whom anticipate the need for rehabilitation to get back on their feet. But if patients improve their physical and mental ...

Flu vaccine performance varies by age, study reveals

New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune system that help to protect against infection varied greatly depending on the vaccine type and age ...

Study reveals why some myeloma patients stay cancer-free for years after CAR T therapy

A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of blood cancer, stay in remission for many years after receiving CAR T cell therapy, while others see ...

Researchers aim to disrupt breast cancer line of communication and prevent spread

Cancer Center at Illinois (CCIL) Program Leader Erik Nelson's lab made an important discovery about the relationship between cholesterol and breast cancer progression with crucial implications for breast cancer therapeutics.

Study tracking how tumor microenvironment develops signals opportunity for early detection, risk prediction

Colorectal cancer precursor lesions are benign growths that can develop into colorectal cancer (CRC) over time, through either a conventional or serrated pathway. Understanding how the immune system reacts to these precursor ...

Rapid growth of radiopharmaceutical therapy highlights need for expertise

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining the education, training, and experience needed to ensure the safe and effective delivery of radiopharmaceutical therapy ...

Newly identified lymphoma subtype gives hope in fight against aggressive form of blood cancer

Researchers at the University of Southampton have identified a new subtype of lymphoma that could pave the way to improved and more targeted treatments for some blood cancer patients. The cancer scientists and biologists ...

Blood test offers hope for more effective ovarian cancer treatment

New clinical research has identified a blood test that can reveal which women are more likely to respond to a particular treatment for ovarian cancer, known as PARP inhibitor therapy.

Q&A: Connection between a distinct immune cell and colitis discovered

CU Anschutz researchers uncovered a link between a type of mucosal immune cell and gut inflammation, finding that the cells exacerbate inflammation and lead to chronic disease in certain conditions.

FDA grants fast track designation to drug combo for colorectal cancer

The U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal cancer, following encouraging results from a clinical trial led in part by the University of Oklahoma ...

T cell therapies show long-term HPV gains

Researchers from Rutgers Cancer Institute, New Jersey's only National Cancer Institute (NCI)—designated Comprehensive Cancer Center, and RWJBarnabas Health, along with colleagues from the National Cancer Institute, a center ...

Sleep issues linked to higher risk of severe asthma in children

About 30 to 40% of children with asthma experience sleep difficulties due to symptoms like coughing and wheezing. Poor sleep increases the risk of severe asthma exacerbations (attacks) that often necessitate a hospitalization ...

Largest study on infant-type hemispheric glioma reports factors to guide treatment approaches

Clinician-scientists at St. Jude Children's Research Hospital and collaborators have conducted the largest study of infant-type hemispheric glioma (IHG) ever reported, uncovering key factors that could be used to guide treatment ...

What is myasthenia gravis, the rare disease tennis great Monica Seles lives with?

Former tennis star Monica Seles recently revealed she is living with the rare disease myasthenia gravis, which affects 12 in 100,000 people globally.

Factoring in frailty and age could improve pancreatic cancer treatment

While some risk factors for cancer can be mitigated through lifestyle choices such as diet or exercise, aging is not one of them. In the case of pancreatic cancer, it also can limit treatment options if a patient is too frail ...

Recommended News For You

Three out of ten breast cancers detected between screenings, study finds

Having dense breasts is linked to cancer, but advice about breast density can depend on where you live

The lack of psychiatrists may be addressed by community workers.

Immunotherapy in Head and Neck Cancer After Failure of Definitive Therapy.

A study suggests that screening for liver cancer is beneficial for patients with cirrhosis.

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

Liquid Biopsy for Colorectal Cancer Screening Might Not Be Ready for Prime Time.

Recommended Articles For You

The Crucial Role of Antithrombin 3 in Preventing Blood Clots: A Comprehensive Guide 

The Capmist DM: A Revolutionary Way to Combat Dry Mouth 

Managing High Potassium Levels: A Comprehensive Guide to Veltassa  

Potential of Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies

2.

Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice

3.

Many women undergo annual mammography, despite biennial screening recommendations

4.

High-speed whole-body SPECT tracks tumor evolution to optimize prostate cancer treatment

5.

Mammo Responsibility Increases Screening; Opioids for Pain Related to Cancer? Ignored CRC Signs.

1.

Uncovering Breast Cancer: The Power of Early Stage Ultrasound

2.

Demystifying Lymphocytes: Everything You Need to Know 

3.

Is AI The New Radiologist For Breast MRI?

4.

AI in Genomics: Decoding the Human Genome for Cancer Treatment

5.

Understanding Vaso Occlusive Crisis: Symptoms, Causes, and Management Strategies

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective

2.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

4.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot